Cellular Vaccine Approaches

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Novel Vaccine Approaches

Shiver (Abstract S4) reviewed the strategy that he and his colleagues have developed for standardized assessment of T cells through development of short-term stimulation with peptide pools and ELISPOT assays that detect cytokine-secreting cells. Studies in HIV-infected individuals showed that ELISPOT assays can reproducibly and quantitatively measure cell-mediated responses to a variety of HIV ...

متن کامل

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand

Background The World Health Organization (WHO) has developed the Total System Effectiveness (TSE) framework to assist national policy-makers in prioritizing vaccines. The pilot was launched in Thailand to explore the potential use of TSE in a country with established governance structures and accountable decision-making processes fo...

متن کامل

Old and new vaccine approaches.

The conventional, currently available vaccines, though quite successful, suffer from a few shortcomings which hamper future vaccine development. We present herewith some of the new approaches that are presently being pursued, including (1) the development of recombinant, or genetically engineered, vaccines which are based either on the expression of the relevant protective antigen and its formu...

متن کامل

Approaches Applied to Vaccine Development

Vaccines represent one of the most cost-effective ways to prevent and treat diseases. The use of vaccines in the control of viral diseases represents an important milestone in the history of medicine. The genomic revolution brought us the possibility to scan genomes in the search of new and more effective vaccine candidates and the advancement of bioinformatics provided the framework for the ap...

متن کامل

Hepatitis C vaccine approaches phase II trial.

The fi rst prophylactic hepatitis C vaccine to reach human trials could enter phase II testing this year, a landmark for a fi eld that has faced many technical challenges since the virus was identifi ed in 1989. If this vaccine — or one of several other candidates — is successful, the public health impact could be substantial. Hepatitis C is a major cause of liver disease, including hepatocellu...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: The Cancer Journal

سال: 2010

ISSN: 1528-9117

DOI: 10.1097/ppo.0b013e3181eb33d7